1996
DOI: 10.3109/10428199609051608
|View full text |Cite
|
Sign up to set email alerts
|

Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells

Abstract: The lytic response of lymphoid cells to glucocorticoid hormones (GC) is prototypical of the induction of apoptosis: a special form of cellular demise for the removal of unwanted or redundant cells. Initiation and execution of a death programme are therefore major checkpoints in GC-sensitivity. Although Bcl-2 protein can prevent or delay apoptosis of lymphoma and leukemia cells, exposed to multiple cytotoxic agents, its antagonism of GC-induced apoptosis appears most critical in conferring resistance to cortico… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0

Year Published

1997
1997
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(21 citation statements)
references
References 45 publications
1
19
0
Order By: Relevance
“…34 Accordingly, a decrease in the level of mono(ADP-ribose) adducts in GC receptor-associated HSP90 proteins could possibly be a common stress-sensing event and the target process of MIBG action, eg by inhibiting the reassociation of the heat-activated receptor complexes (Figure 7). At minimally toxic doses the antimitochondrial drug rotenone did not reproduce the potentiations by MIBG, but has comparable effects on cellular ATP content in these 17 and other cell lines. 14 This observation and the failing potentiation by MIBG to cold argue against an important role of antimitochondrial effects of MIBG in the potentiation of Bcl-2-negative S49 variants, contrary to previous findings in Bcl-2 overexpressing lymphoma cells.…”
Section: Discussionmentioning
confidence: 82%
See 2 more Smart Citations
“…34 Accordingly, a decrease in the level of mono(ADP-ribose) adducts in GC receptor-associated HSP90 proteins could possibly be a common stress-sensing event and the target process of MIBG action, eg by inhibiting the reassociation of the heat-activated receptor complexes (Figure 7). At minimally toxic doses the antimitochondrial drug rotenone did not reproduce the potentiations by MIBG, but has comparable effects on cellular ATP content in these 17 and other cell lines. 14 This observation and the failing potentiation by MIBG to cold argue against an important role of antimitochondrial effects of MIBG in the potentiation of Bcl-2-negative S49 variants, contrary to previous findings in Bcl-2 overexpressing lymphoma cells.…”
Section: Discussionmentioning
confidence: 82%
“…Conceptually, cross-resistance of H.2 cells could be due to autocrine production of growth/survival factors, which can rescue several cells of T origin from apoptosis by DEX and low serum. [15][16][17] Because interleukins have been reported to protect T cells by maintaining or upregulating Bcl-2 levels, 15,32 the failure to rescue S49 cells from DEX and low serum by exogenous interleukins, and by inference the H.2 cells by autocrine growth factors, may be attributed to the intrinsically low expression of the bcl-2 gene.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, it can not be excluded that these few patients were resistant due to other, Bcl-2-independent mechanisms, eg by deficiencies in hormone binding and receptor activation. [32][33][34] We and others did not find an independent relationship between Bcl-2 and treatment outcome. 12,13 In addition, the present study indicates no gain in prognostic information by including Bax, Bak, Bcl-x L and Bad.…”
Section: Discussionmentioning
confidence: 92%
“…However, these effects are transient in the continuous presence of GC, and Bcl-2 does not prevent cell cycle arrest (Hartmann et al 1999), altogether limiting its potential in a selection process that requires both proliferation and survival. In any case, expression of anti-apoptotic Bcl-2 members is frequent in leukemic cell lines and primary cells from patients prior to, and particularly after combination chemotherapy, and has been associated with resistance to chemotherapeutic drugs and GC (Smets & Van den Berg 1996, Salomons et al 1997.…”
Section: Gc Resistance As Results Of Inhibitory Cross-talk At the Effementioning
confidence: 99%